NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Biomedical Advanced Research and Development Authority (BARDA)

Biomedical Advanced Research and Development Authority (BARDA)

District of Columbiaaspr.hhs.gov

Overview

BARDA is a U.S. government entity within the Department of Health and Human Services that provides funding and support for the development and procurement of medical countermeasures. It aims to protect against bioterrorism (including chemical, biological, radiological, and nuclear threats), pandemic influenza, and emerging infectious diseases by partnering with private industry to move products from early development into the Strategic National Stockpile.

Portfolio Companies

12

Investments

CompanyDateStageLead
LTS Lohmann Therapie-Systeme AGJan 2025GrantLead
CyanVac LLCJun 2024GrantLead
Locus BiosciencesJan 2024GrantCo-investor
HDT Bio Corp.Jan 2024GrantCo-investor
VenatoRxOct 2023GrantCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersDistrict of Columbia
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




ProductsSecondary Data & TradingCaplight MarketPrice™Company DatabaseInvestor DatabaseSourcingAPI & MCP

Use CasesInvestorsEmployees

ResourcesResearch & BlogAboutCareers

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.